Tardive Dyskinesia, also known as neuroleptic-induced tardive dyskinesia, is related to movement disease and parkinsonism, and has symptoms including spasmodic torticollis and myoclonus. An important gene associated with Tardive Dyskinesia is NQO1 (NAD(P)H Quinone Dehydrogenase 1), and among its related pathways/superpathways are Glucose / Energy Metabolism and Neuroscience. The drugs Aripiprazole and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include tongue and brain, and related phenotypes are akathisia and tardive dyskinesia